Table 2.
Variable | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
Gender | - | - | |||
Male | Reference | ||||
Female | 0.85 (0.53-1.36) | 0.495 | |||
Age(years) | - | - | |||
≤42 | Reference | ||||
>42 | 0.32 (0.19-0.53) | <0.001 | |||
Family history | - | - | |||
Yes | Reference | ||||
No | 0.92 (0.58-1.46) | 0.735 | |||
Smoking behavior | - | - | |||
Yes | Reference | ||||
No | 1.03 (0.69-1.53) | 0.901 | |||
TNM stage | 1.40 (1.06-1.86) | 0.019 | |||
I | Reference | ||||
II | 1.08 (0.40-2.87) | 0.885 | |||
III | 2.75 (1.43-5.30) | 0.003 | |||
IV | 6.61 (3.35-12.72) | <0.001 | |||
Histological type | - | - | |||
Adenocarcinoma | Reference | ||||
Squamous cell carcinoma |
0.89 (0.58-1.38) | 0.603 | |||
Other | 1.68 (0.68-4.17) | 0.265 | |||
Size(cm) | - | - | |||
≤6.0 | Reference | ||||
>6.0 | 2.35 (1.50-3.70) | <0.001 | |||
Treatment | 1.76 (1.28-2.40) | <0.001 | |||
Surgery | Reference | ||||
Surgery and Radiotherapy/ Chemotherapy |
0.91 (0.47-1.74) | 0.772 | |||
Radiotherapy/ Chemotherapy |
3.80 (2.11-6.84) | <0.001 | |||
Other | 6.99 (3.47-14.06) | <0.001 | |||
ALB(g/L) | - | - | |||
≤37.6 | Reference | ||||
>37.6 | 0.40 (0.25-0.66) | <0.001 | |||
CRP(mg/L) | 1.76 (1.09-2.84) | 0.020 | |||
≤9.5 | Reference | ||||
>9.5 | 2.70 (1.81-4.03) | <0.001 | |||
WBC (10^9/L) | - | - | |||
≤10.0 | Reference | ||||
>10.0 | 1.92 (1.17-3.14) | 0.009 | |||
Neutrophil(10^9/L) | - | - | |||
≤7.5 | Reference | ||||
>7.5 | 2.66 (1.61-4.40) | <0.001 | |||
Lymphocyte(/10^9/L) | - | - | |||
≤1.8 | Reference | ||||
>1.8 | 0.80 (0.54-1.19) | 0.268 | |||
Platelet(10^9/L) | 0.43 (0.22-0.83) | 0.012 | |||
≤163 | Reference | ||||
>163 | 0.50 (0.30-0.84) | 0.009 | |||
NLR | - | - | |||
≤4.30 | Reference | ||||
>4.30 | 3.30 (1.96-5.55) | <0.001 | |||
PLR | - | - | |||
≤109.5 | Reference | ||||
>109.5 | 1.57 (1.04-2.38) | 0.034 | |||
PNI | - | - | |||
≤48.1 | Reference | ||||
>48.1 | 0.40 (0.26-0.63) | <0.001 |